Xtant Medical Holdings, Inc.
XTNT Healthcare Medical Devices
Xtant Medical Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $133.9 million, up 14.2% from fiscal 2024. In the quarter to June 2026, revenue fell 35.0%, EPS fell 333.3%, free cash flow fell 882.0% and total debt fell 33.0%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
Follow XTNT
Xtant Medical Holdings, Inc. (XTNT) P/E ratio
Xtant Medical Holdings, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 139× (December 2023) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 19.1× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 27.5× | 43.59% |
| Dec 2025 | 19.1× | (40.00%) |
| Sep 2025 | 31.9× | — |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| TELA TELA Bio, Inc. compare | n/m |
| MDAI Spectral AI, Inc. compare | n/m |
| NNOX Nano-X Imaging Ltd. compare | n/m |
| CVRX CVRx, Inc. compare | n/m |
| TLIS Talis Biomedical Corporation compare | n/m |
| RPID Rapid Micro Biosystems, Inc. compare | n/m |
| SRTS Sensus Healthcare, Inc. compare | n/m |
| XTNT Xtant Medical Holdings, Inc. | n/m |
| SNWV Sanuwave Health Inc. compare | 3.0× |
| Medical Devices industry median | 23.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)